Effects of the differentiated keratinocyte phenotype on expression levels of CYP1-4 family genes in human skin cells

被引:47
作者
Du, Liping
Neis, Mark M.
Ladd, Patricia A.
Lanza, Diane L.
Yost, Garold S.
Keeney, Diane S.
机构
[1] VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Sch Med, Dept Med Dermatol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[4] Univ Hosp Aachen, Dept Dermatol, Aachen, Germany
[5] Univ Hosp Aachen, Dept Allergol, Aachen, Germany
[6] Rhein Westfal TH Aachen, D-5100 Aachen, Germany
[7] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
关键词
cytochrome P450; CYP; epoxygenase; eicosanoids; keratinocyte; skin; epidermis; epithelial differentiation;
D O I
10.1016/j.taap.2005.10.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Epoxyeicosatrienoic acids produced by mouse CYP2B19 have been implicated in mechanisms regulating epidermal cornification (Ladd, P.A., Du, L., Capdevila, J.H., Mernaugh, R., Keeney, D.S., 2003. Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes. J. Biol. Chem. 278, 35184-35192). In this study, we aimed to identify CYPs that are up-regulated during keratinocyte differentiation and potentially responsible for epoxyeicosatrienoic acid formation in human skin. The cellular differentiation state of human epidermal cell cultures was manipulated to resemble the basal, spinous, and granular cell phenotypes in vivo. Changes in CYP mRNA levels were measured as a function of differentiation state for a panel of 15 CYPs that included known and putative arachidonate monooxygenases. Quantitative real-time PCR analyses showed that all of the CYPs were expressed in differentiating epidermal cell cultures and in human epidermis, with the exception of CYP2B6, which was poorly expressed in vitro. Six CYPs were strongly up-regulated at Day 6 and Day 8 of in vitro differentiation (CYP4B1, 2W1, 2C18, 3A4, 2C19, 2C9); the increase in mRNA levels ranged from 27- to 356-fold. Only CYP2U1 mRNA levels decreased (6-fold change) during cellular differentiation. Six CYPs showed little variation (< 2-fold change) in mRNA levels during in vitro differentiation (CYP2S1, 2J2, 1B1, 1A1, 2E1, 2D6). No single CYP was identifiable as being a functional counterpart to CYP2B19 in mouse skin since none qualified as being mainly responsible for epidermal epoxyeicosatrienoic acid formation. Rather, the data suggest that epoxyeicosatrienoic acids in human skin are formed by several CYPs expressed in different cell layers of the epidermis. This would predict that CYP-derived eicosanoids have different functions in different epidermal cell layers. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 54 条
[1]   Cytochrome P450: A target for drug development for skin diseases [J].
Ahmad, N ;
Mukhtar, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (03) :417-425
[2]  
BICKERS DR, 1982, MOL PHARMACOL, V21, P239
[3]   Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles [J].
Bylund, J ;
Finnström, N ;
Oliw, EH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (01) :169-174
[4]   Characterization of pulmonary CYP4B2, specific catalyst of methyl oxidation of 3-methylindole [J].
Carr, BA ;
Ramakanth, S ;
Dannan, GA ;
Yost, GS .
MOLECULAR PHARMACOLOGY, 2003, 63 (05) :1137-1147
[5]  
Cartlidge P, 2000, Semin Neonatol, V5, P273, DOI 10.1053/siny.2000.0013
[6]  
Chandler DP, 1998, APPL ENVIRON MICROB, V64, P669
[7]   Rabbit CYP4B1 engineered for high-level expression in Escherichia coli:: ligand stabilization and processing of the N-terminus and heme prosthetic group [J].
Cheesman, MJ ;
Baer, BR ;
Zheng, YM ;
Gillam, EMJ ;
Rettie, AE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 416 (01) :17-24
[8]  
CHOUDHARY D, 2003, ARCH BIOCHEM BIOPHYS, V436, P50
[9]   CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes ω- and (ω-1)-hydroxylation of fatty acids [J].
Chuang, SS ;
Helvig, C ;
Taimi, M ;
Ramshaw, HA ;
Collop, AH ;
Amad, M ;
White, JA ;
Petkovich, M ;
Jones, G ;
Korczak, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (08) :6305-6314
[10]  
COOMES MW, 1983, J PHARMACOL EXP THER, V225, P770